|
Main conference will be simultaneously translated
提供同声传译服务
CELL LINE DEVELOPMENT & ENGINEERING ASIA brings together experts and top scientists from biopharmas, biotechs, CMOs and research institutes as well as leading technology providers from Asia and globally. The region’s 1st and ONLY focused Cell Line Development and Engineering Asia provides a forum where industry experts share lessons learned through case studies, strategic discussion groups and interactive roundtables to collectively collaborate and provide solutions to your most pressing challenges. Bring back new ideas to do better business.
亚洲细胞株开发和工学技术会议 吸引了来自生物制药界、生物技术界、全球生物制药合同生产组织 (CMO) 和研究机构的专家和顶级科学家，以及亚洲和全球的领军技术提供商齐聚一堂。首次在该地区所举办的亚洲细胞株系开发和工学技术会议将为业界专家们提供一个平台，他们将通过案例研究、战略性讨论小组和互动性圆桌会议等方式分享彼此经验，从而共同合作探讨出各式解决方案，帮助您应对最紧迫的挑战。 同时引进新观点，进一步促进业务发展。
Academic Keynote Speaker:
Prof Michael Betenbaugh
Professor and former Chair of Department,
Chemical and Biomolecular Engineering,
Johns Hopkins University, USA |
Industry Keynote Speaker:
Dr Jianguo Yang
Principal Scientist,
Genzyme / Sanofi Aventis, USA |
| CONFIRMED SPEAKERS |
.png) |
Dr Lin Zhang
Associate Research Fellow,
Pfizer, USA |
|
 |
Dr Ralf Schumacher
Head of Biologics Research, Pharma
Research and Early Development,
Roche Diagnostics, Germany |
|
 |
Dr Zhiwei Song
Senior Scientist,
BTI A*Star, Singapore |
|
|
Dr Cheng Liu
Chief Executive Officer,
Eureka Therapeutics, USA |
|
 |
Dr Chichang Lee
Vice President,
Zhejiang Teruisi Pharmaceutical, China |
|
|
Dr Steven Lee
Global Head of Biologics,
Luye Pharmaceuticals, Singapore |
|
 |
Dr Rustom Mody
Executive Vice President,
Intas Biopharmaceuticals, India |
|
|
Dr Baoping Wang
Vice President and Head of R&D,
Novo Nordisk, China |
|
|
Dr Weidong Jiang
CSO and Vice President,
Henlix Biopharmaceuticals, USA |
|
|
Dr Yang Yuan Sheng
Research Scientist,
BTI, A*Star, Singapore |
|
|
Dr Feng Gao
Chief Operating Officer,
AutekBio (Beijing), China |
|
 |
Dr Nigel Jenkins
Head of Process Development,
Neuclone, Australia |
|
 |
Dr Emmanuel Guerevitz
Chief Executive Officer,
Amagino Biotechnology, Israel |
|
|
Dr Shun Luo
President,
JS Biosciences, China |
|
Why You Should Attend:
为什么您应该参加： |
- Asia’s first and only conference focused on Cell Line Development and Engineering from the same company with established events bringing together cell line experts in US and Europe
- Hear from and personally meet experts in cell line development and engineering as they provide latest updates and case studies to learn and draw new opportunities from
- Featuring case studies from biopharma, research institutes and biotechs to review available technologies, products and suppliers and to discuss cost effective and quality process development
- The most comprehensive event highlighting key challenges in cell line development and engineering including best practices, improving cell banking , optimising selection process and subsequent cell line development, IP and regulatory issues
- Practical how-to workshops from regional and global experts
- 这是亚洲首次、也是唯一一次以亚洲细胞株开发和工学技术为主题的会议，主办此次活动的公司在举办此类活动方面有着极其丰富的经验，这次又将美国和欧洲地区的细胞株专家齐聚一堂。
- 本次会议中，来自生物制药界、研究机构和生物技术界的代表将通过案例研究审视现有技术、产品和供应商，同时探讨成本效益和质量流程开发问题
- 此次会议涵盖范围非常广，聚焦细胞株开发和工学技术领域所面临的主要挑战，包括最佳实践方法、改善细胞建库流程、优化选择流程以及随后的细胞株开发、知识产权和法规监管问题
- 考察亚洲生物制药行业合作机会
- 向国际专家学习，发现细胞株开发领域所面临的挑战和差距
- 审视美国、欧洲和亚洲地区法规
|
| Key themes and issues include: |
- Examining the Business and Regulatory Landscape
- Cell Line Development Approaches for Biosimilars
- Addressing Timeline Bottlenecks in Development
- Implementing Successful Cell Line Strategies
- Screening and Automation, Clone Selection,
Expression and Cell Line Stability
- Optimizing Process Development
|
Call for Poster Presentations:
Poster sessions offer a unique opportunity to have your scientific research projects displayed at this conference.
Submit your abstract. You must be a confirmed attending delegate to qualify to present a poster.
Submit abstract of 100 words or less, written in English to elle.quan@ibcasia.com.sg.
Deadline for submission is 23 January 2012 |
|
Post-conference Workshop: 23 February
Solutions for Asia Biologic Development
|
|
|
|
|
Co-located with |
The 4th Annual Antibodies Asia Summit 2012 is the region’s premier
conference on Antibodies Research & Development. Top scientists
from pharma/biotech, universities and research institutes will convene
in Shanghai to discuss the challenges, trends and collaboration
opportunities in conducting Antibodies Research in Asia.
Featuring the latest antibody research and development, industry trends and updates and ways to expedite your antibody pipeline into revenue-generating biologics. www.antibodiesasia.com
聚焦于最新抗体研发、行业发展趋势和最新动向 ， 以及加快抗体系列产品向可创收生物制剂的转变方法。具体请访问
www.antibodiesasia.com
|
|
